Pharma Journalist -

Mirati Therapeutics, Inc. announced a clinical collaboration agreement with Novartis to evaluate the combination of MRTX849, Mirati's investigational KRAS G12C inhibitor and TNO155,…
Read More...

Lyndra Therapeutics, the company making daily pills a thing of the past, has announced a partnership with Gilead Sciences, Inc. to develop and commercialize ultra-long-acting oral HIV…
Read More...

Amidst a (r)evolution in pharmaceutical strategy, Real World Evidence is more than ever a key driver of growing innovation in product life cycle. Leading organizations are rethinking…
Read More...

SMi Report: Respiratory Drug Delivery conference will be taking place on 5th – 6th December 2019, the brochure is now available to download. With the rising prevalence of respiratory…
Read More...

SunGen Pharma announced it has received its sixth ANDA approval from the US Food and Drug Administration (FDA). The sixth approved ANDA is for Methylprednisolone tablets, 4 mg. This…
Read More...

Ligand Pharmaceuticals Incorporated and SQ Innovation AG announced that the two companies have entered into long-term, exclusive commercial license and supply agreements for use of…
Read More...

SMi’s inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on…
Read More...

BeiGene, Ltd. announced that the China National Medical Products Administration (NMPA, formerly known as the CFDA) has granted priority review status to the supplemental new drug…
Read More...

Grifols announced that Xembify, its new 20% subcutaneous immunoglobulin, has been approved by the U.S. Food and Drug Administration (FDA). Xembify is used to treat primary…
Read More...

SMi Reports: Senior experts from Optima and Optima Pharma to lead a post-conference workshop during Lyophilization USA, convening October 23rd to 24th 2019 Delegates for the 5th…
Read More...